Last week, Jennifer Lawrence and other celebrities had indiscrete photos stolen and distributed across the Internet. It’s speculated that their accounts were accessed by a “brute force” attack—which can only be successful if their passwords were weak.
Weak passwords are a risk for businesses, too. Verizon found that 76% of all network intrusions exploit weak or stolen passwords.
To protect critical data, every employee at every business must use strong passwords (which have no fewer than 12 characters). But with an average of 14.3 apps per business, users are likely to take shortcuts by creating passwords that are easy to memorize – and easy to crack.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7286151-intermedia-appid-single-sign-on-passwords-one-click-access/
This fall Ann Taylor tells the story of the multifaceted lives women live today. Told through the lens of famed fashion photographer Mikael Jansson and the real life of actress Kate Hudson, the campaign portrays the story of smart, stylish women who make things happen their way, 24/7. It’s about women who transition with style from one moment to the next in their busy, brilliant lives, and are authentic, inspiring and generous in everything they do.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58232-ann-taylor-kate-hudson-strong-stylish-women-moms-balanced-lifestyles
Based on thorough market analysis, Frost & Sullivan recognizes Toon Boom Animation Inc. with the 2011 Global Frost & Sullivan Award for Entrepreneurial Company of the Year. In a highly concentrated market, in which the top three companies hold nearly 67 percent of the market share, Toon Boom has shown remarkable entrepreneurial spirit, rapidly gaining a strong foothold through product innovation, marketing and the implementation of a well-rounded strategy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56394-toon-boom-2011-frost-sullivan-award-entrepreneurial-company-of-the-year
http://www.andrewsforexsystem.com/ Andrew's Forex System makes extensive use of information technology making it available to everyone. Traders can profit from both strong and weak economies. Trader can place very short-term orders which are prohibited in some other markets.
A new report on strategic account manager (SAM) compensation found that SAM roles continue to grow in importance. Key indicators include the large percentage of future growth companies expect from their strategic accounts and increased investment that companies are making in their SAM programs. Strategic account management is a company-wide initiative in complex, highly matrixed organizations that focuses on building strong and mutually beneficial relationships with a firm's most important customers and partners.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64374-sama-zs-associates-strategic-account-manager-programs
The Smithsonian's National Museum of American History will open a new exhibition on American business July 1 in the Mars Hall of American Business. The exhibition, “American Enterprise” will have a strong focus on the nation's agriculture history which is one of four economic sectors in the exhibition. It will explore precision farming, environmental concerns and hybrid seeds.
“American agriculture has gone through a tremendous transformation in the past seven decades, becoming a high-tech industry, deeply affecting not just farmers themselves but every American and the American experience in general,” said Peter Liebhold, museum curator and chair of the Division of Work and Industry.
The companion book American Enterprise: A History of Business in America, will highlight significant artifacts from agriculture's humble beginnings to the technological advances that make it a leading industry in the United States.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7433931-national-museum-of-american-history/
CARRERA, the international fashion eyewear brand, presents its new worldwide communication campaign with strong-impacting images to attract public attention the world over.
Conceived and promoted by the agency D’Adda, Lorenzini, Vigorelli, BBDO, the campaign focuses on the narrative aspect of new communication with a portrait of a generation engaged in living life to the full and enjoying every moment. The message is direct and immediate, due to the clear and absorbing headline, “AFTER ALL, NO REGRETS”. This is a prompt to live life intensely, with personality and without regrets, with CARRERA sunglasses and optical frames as inseparable companions at all times.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/carrera/47596/
During the third quarter, we were again able to capture the benefits of AEGON’s strategic priorities, resulting in solid earnings growth, improved profitability of sales, lower expenses and a continued strong capital position. Our franchise remains healthy, as evidenced by the particularly high level of At-Retirement and pension sales. At the same time, we are making essential investments to reshape our businesses in both our established and developing markets to respond effectively to the changing conditions and new realities. Although there are signs of gradually improving market conditions, there remains considerable uncertainty in the general economic environment. Consequently, we believe it is prudent and necessary to maintain a sufficient financial buffer while at the same time adhering to our strict risk and pricing discipline. The steps we are taking across our organization to get closer to our end customers, combined with the strength of our current position, give us full confidence in the prospects for our business going forward.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58637-aegon-quarter-3-results
AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches with an estimated $18 billion in annual revenues and a strong commitment to creating shareholder value through long-term growth potential and the continuation of the company’s history of shareholder dividends.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59757-abbvie-celebrates-launch-as-new-biopharmaceutical-company
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
